The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Agenus Inc | COM NEW | 00847G705 | 16,007 | 4,245,882 | SH | SOLE | 1 | 4,245,882 | 0 | 0 | |
Alnylam Pharmaceuticals Inc | COM | 02043Q107 | 55,991 | 1,092,516 | SH | SOLE | 1 | 1,092,516 | 0 | 0 | |
Arbutus Biopharma Corp | COM | 03879J100 | 4,701 | 1,446,587 | SH | SOLE | 1 | 1,446,587 | 0 | 0 | |
Atara Biotherapeutics Inc | COM | 046513107 | 18,674 | 908,733 | SH | SOLE | 1 | 908,733 | 0 | 0 | |
Avexis Inc | COM | 05366U100 | 47,392 | 623,330 | SH | SOLE | 1 | 623,330 | 0 | 0 | |
BioCryst Pharmaceuticals Inc | COM | 09058V103 | 29,048 | 3,458,120 | SH | SOLE | 1 | 3,458,120 | 0 | 0 | |
Biopharmx Corp | COM | 09072X101 | 648 | 1,283,951 | SH | SOLE | 1 | 1,283,951 | 0 | 0 | |
bluebird bio Inc | COM | 09609G100 | 9,419 | 103,617 | SH | SOLE | 1 | 103,617 | 0 | 0 | |
Bristol-Myers Squibb Co | COM | 110122108 | 31,034 | 570,692 | SH | SOLE | 1 | 570,692 | 0 | 0 | |
Celldex Therapeutics Inc | COM | 15117B103 | 873 | 241,699 | SH | SOLE | 1 | 241,699 | 0 | 0 | |
Corium International Inc | COM | 21887L107 | 6,057 | 1,448,991 | SH | SOLE | 1 | 1,448,991 | 0 | 0 | |
Dicerna Pharmaceuticals Inc | COM | 253031108 | 7,014 | 2,062,991 | SH | SOLE | 1 | 2,062,991 | 0 | 0 | |
Global Blood Therapeutics Inc | COM | 37890U108 | 965 | 26,183 | SH | SOLE | 1 | 26,183 | 0 | 0 | |
Incyte Corp | COM | 45337C102 | 11,026 | 82,490 | SH | SOLE | 1 | 82,490 | 0 | 0 | |
Invuity Inc | COM NEW | 46187J205 | 3,738 | 470,167 | SH | SOLE | 1 | 470,167 | 0 | 0 | |
La Jolla Pharmaceutical Co | COM PAR $.0001 2 | 503459604 | 30,714 | 1,028,929 | SH | SOLE | 1 | 1,028,929 | 0 | 0 | |
Masimo Corp | COM | 574795100 | 7,545 | 80,900 | SH | SOLE | 1 | 80,900 | 0 | 0 | |
Medicines Co | COM | 584688105 | 28,004 | 572,689 | SH | SOLE | 1 | 572,689 | 0 | 0 | |
Natera Inc | COM | 632307104 | 281 | 31,693 | SH | SOLE | 1 | 31,693 | 0 | 0 | |
OraSure Technologies Inc | COM | 68554V108 | 7,321 | 566,230 | SH | SOLE | 1 | 566,230 | 0 | 0 | |
Oxford Immunotec Global PLC | ORD SHS | G6855A103 | 9,494 | 612,903 | SH | SOLE | 1 | 612,903 | 0 | 0 | |
PTC Therapeutics Inc | COM | 69366J200 | 12,848 | 1,305,643 | SH | SOLE | 1 | 1,305,643 | 0 | 0 | |
Regenxbio Inc | COM | 75901B107 | 23,479 | 1,216,505 | SH | SOLE | 1 | 1,216,505 | 0 | 0 | |
Sensus Healthcare Inc | COM | 81728J109 | 397 | 90,404 | SH | SOLE | 1 | 90,404 | 0 | 0 | |
Tactile Systems Technology Inc | COM | 87357P100 | 5,455 | 287,876 | SH | SOLE | 1 | 287,876 | 0 | 0 | |
Viewray Inc | COM | 92672L107 | 4,388 | 515,612 | SH | SOLE | 1 | 515,612 | 0 | 0 | |
Viveve Medical Inc | COM NEW | 92852W204 | 7,253 | 1,145,736 | SH | SOLE | 1 | 1,145,736 | 0 | 0 | |
Sensus Heatlhcare Inc | *W EXP 06/08/201 | 81728J117 | 136 | 155,000 | SH | SOLE | 1 | 155,000 | 0 | 0 |